Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bispecific antibodies targeting human claudin 18.2 and programmed death-ligand 1 (PD-L1)

Bispecific antibodies targeting human claudin 18.2 and programmed death-ligand 1 (PD-L1)

US Patent 11970533 · Granted Apr 30, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Powder type polypropylene resin and method for preparing the same2025
Nucleic acid nanoswitch construction methods2025
Binding molecules specific for claudin 18.2, compositions and methods thereof, f2022
Binding molecules specific for claudin 18.2, compositions and methods thereof, f2022
Binding molecules specific for claudin 18.2, compositions and methods thereof, f2022
Binding molecules specific for claudin 18.2, compositions and methods thereof, f2022
Indane inhibitors of EED and methods of their use2018
Modulators of 5-HT receptors and methods of use thereof2018
Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors2017
Pyrrolidine derivatives, pharmaceutical compositions containing them, and their 2017
Pyrrolidine derivatives, pharmaceutical compositions containing them, and their 2017
Aminotetraline and aminoindane derivatives, pharmaceutical compositions containi2017